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Abstract
Sample size calculations are advocated by the CONSORT group to justify sample sizes in randomized controlled trials (RCTs).
The aim of this study was primarily to evaluate the reporting of sample size calculations, to establish the accuracy of these
calculations in dental RCTs and to explore potential predictors associated with adequate reporting. Electronic searching was
undertaken in eight leading specific and general dental journals. Replication of sample size calculations was undertaken
where possible. Assumed variances or odds for control and intervention groups were also compared against those
observed. The relationship between parameters including journal type, number of authors, trial design, involvement of
methodologist, single-/multi-center study and region and year of publication, and the accuracy of sample size reporting was
assessed using univariable and multivariable logistic regression. Of 413 RCTs identified, sufficient information to allow
replication of sample size calculations was provided in only 121 studies (29.3%). Recalculations demonstrated an overall
median overestimation of sample size of 15.2% after provisions for losses to follow-up. There was evidence that journal,
methodologist involvement (OR = 1.97, CI: 1.10, 3.53), multi-center settings (OR = 1.86, CI: 1.01, 3.43) and time since
publication (OR= 1.24, CI: 1.12, 1.38) were significant predictors of adequate description of sample size assumptions. Among
journals JCP had the highest odds of adequately reporting sufficient data to permit sample size recalculation, followed by
AJODO and JDR, with 61% (OR= 0.39, CI: 0.19, 0.80) and 66% (OR= 0.34, CI: 0.15, 0.75) lower odds, respectively. Both
assumed variances and odds were found to underestimate the observed values. Presentation of sample size calculations in
the dental literature is suboptimal; incorrect assumptions may have a bearing on the power of RCTs.
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Introduction
Randomized controlled trials (RCTs) are considered the gold
standard for assessing the efficacy and safety of an intervention
and are the bedrock of evidence-based practice in medicine and
dentistry. Appropriate planning of RCTs ensures validity and
precise estimation oftreatment effects [1].
To increase precision in identifying a difference between
treatment modalities if such a difference exists beyond chance,
an a priori estimation of the appropriate number of participants to
be included in the trial is required [2,3]. Additionally, given the
implications of RCTs in terms of time and resources, recruitment
of the appropriate number of patients is imperative [4].
Unjustifiably large numbers of participants in an RCT may risk
wasting sources, or may even be unethical by exposing participants
to potentially ineffective or harmful treatment. Conversely, small
trials may possess insufficient power to detect a clinically
significant difference, if such a difference exists [5,6,7,8]. In view
of these issues, provision of specific details of sample size
calculations in reports of clinical trials or protocol registries is
recommended in the CONSORT guidelines. This allows replica-
tion of the calculation, verification of appropriate numbers in
trials, and prevention of post hoc decisions to reduce the initially
calculated necessary sample [9,10].
Sample size calculations are based on assumptions concerning
the expected and clinically important treatment effect of the new
intervention compared to the control and its variance (continuous
outcomes only). Additionally, levels of type I error or ‘alpha’, and
type II error (‘beta’) or power must be selected. These assumptions
are either based on previously published research in the same field
or are derived from a pilot study prior to the commencement of
the main trial [11]. Incorrect assumptions concerning the expected
treatment outcomes risks leading to either underpowered studies
or studies that are unnecessarily large [12]. Type I error (‘alpha’) is
usually set at .05 (or less frequently at .01) and refers to the
probability of 5% (or 1%) of observing a statistically significant
difference between the treatment arms when no such difference
exists (false positive). Type II error on the other hand is typically
set at .2 (or .1) and refers to the probability of not identifying a
difference if one exists (false negative). Type II error is more often
expressed in terms of power (1-beta) set at 80% or 90%. Power
indicates the probability of observing a difference between
treatment arms if such a difference exists. Investigators are more
tolerant of false negatives than false positives; this is reflected in the
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difference in what is considered an acceptable level for Type I
(5%) and Type II errors (10% or 20%). Allowance for false positive
and false negative results is unavoidable permitting reasonable
sample sizes, as having statistical power of 100% would necessitate
an infinite number of participants [5,13].
Despite the importance of sample size calculations during trial
design, relatively little attention has been given to the assessment of
their veracity in either the medical and dental literature. A
relatively recent review based on six high impact factor medical
journals revealed that sample size calculations are inadequately
reported and often based on inaccurate assumptions [3].
Table 1. Characteristics of the identified RCTs (n=413).
Sample size adequately reported Sample size inadequately reported Total p-value
Journal No. % No. % No. %
AJODO 45 15 16 13 61 15 ,0.001*
BJOMS 37 13 1 1 38 9
IJP 26 9 6 5 32 8
JCP 63 22 64 53 127 31
JE 55 19 14 12 69 17
PD 16 5 0 0 16 4
JADA 25 9 5 4 30 7
JDR 25 9 15 12 40 10
Continent
Europe 134 46 67 55 201 49 0.16*
Americas 111 38 35 29 146 35
Asia/other 47 16 19 16 66 16
No. authors
1–4 127 43 29 24 156 38 ,0.001*
5–7 131 45 66 55 197 48
.7 34 12 26 21 60 15
Trial design
Cluster 1 0 4 3 5 1 0.02*
Crossover 37 13 12 10 49 12
Factorial 0 0 1 1 1 0
Non-inferiority 3 1 5 4 8 2
Parallel 208 71 86 71 294 71
Splitmouth 43 15 13 11 56 14
Methodologist
involvement
No 245 84 83 69 328 79 ,0.001*
Yes 47 16 38 31 85 21
Center
Single Center 251 86 90 74 341 83 ,0.01*
Multi Center 41 14 31 26 72 17
Significance
No 140 48 53 44 193 47 0.44*
Yes 152 52 68 56 220 53
No. arms
2 238 82 103 85 341 83 0.21*
3 42 14 10 8 52 13
4 8 3 6 5 14 3
5 2 1 1 1 3 1
6 2 1 0 0 2 0
8 0 0 1 1 1 0
Total 292 100 121 100 413 100
*Pearson chi2.
doi:10.1371/journal.pone.0085949.t001
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Suboptimal reporting has also been found in studies published
within dentistry [14,15,16,17,18,19,20,21]. In addition to lack of
reporting or incomplete reporting of sample size calculations,
further issues include whether the recruited numbers are
calculated correctly based on the preset assumptions, and whether
those a priori assumptions hold for the observed results [3]. It is
known that sample size calculation assumptions can be doctored to
approximate the available sample size rather than being truly
based on the correct assumptions. In particular, setting unrealis-
tically large treatment effects, low variances and low power will
result in artificially low sample size requirements. This pattern has
been highlighted for continuous outcomes published in high
impact medical journals, with these studies often underpowered
and predicated on optimistic assumptions [12].
The aim of the present study was to assess the quality and
adequacy of sample size calculations and assumptions in RCTs
published in eight leading journals in the field of dentistry over the
past 20 years, to verify the accuracy of these calculations and to
compare the initial assumptions with the observed values. A
secondary aim was to investigate on an exploratory basis factors
associated with correct performance of sample size calculations in
dental specialty journals.
Materials and Methods
The archives of eight leading dental specialty and general
audience journals with the highest impact factor were screened for
reports of RCTs over the last 20 years (1992–2012), by three
authors (DK, JS, PSF):
- American Journal of Orthodontics and Dentofacial Orthopedics
(AJODO)
- British Journal of Oral and Maxillofacial Surgery (BJOMS)
- International Journal of Prosthodontics (IJP)
- Journal of Clinical Periodontology (JCP)
- Journal of Endodontics (JE)
- Pediatric Dentistry (PD)
- Journal of the American Dental Association (JADA)
- Journal of Dental Research (JDR)
Journals were searched electronically using the terms ‘‘random-
ized’’ or ‘‘randomised’’ in all fields and titles and abstracts were
screened for potential inclusion by two authors (DK, PSF). All
types of trial design were considered including parallel with two or
more arms, split-mouth, crossover, cluster, factorial and non-
inferiority.
Full-text versions of the selected papers with any relevant
additional supplementary material providing details of trial
methodology and sample size calculation were assessed. Data
abstraction forms were developed and two authors (DK, PSF) were
calibrated by piloting 20 selected articles. For each paper all details
contributing to sample estimation were recorded including: Type I
error (alpha), power, assumptions in the interventions and control
groups relating to the outcome under investigation (mean
and standard deviation of difference for continuous outcomes,
proportions or rate of events and difference for dichotomous and
Figure 1. Flowchart of included studies.
doi:10.1371/journal.pone.0085949.g001
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time to event outcomes). The target sample size as indicated by the a
priori sample size calculation, the number of participants recruited
and lost to follow up, and the number of studies presenting
clustering effects accounted for during sample size calculation was
also recorded. Finally, where applicable, the assumed variances
used for sample size calculation and observed variances after
completion of the study were recorded for continuous outcomes.
Assumed and observed Odds Ratios (ORs) and Hazard ratios (HRs)
were recorded for dichotomous and time-to-event outcomes,
respectively. The following additional characteristics were also
recorded for each study: number of authors, geographical region of
the first author (Europe, Americas or Asia/Other), publication year,
single or multi-center study, methodologist involvement, and
statistical significance of the result. Collaboration with a method-
ologist was determined by the affiliation information given for the
authors and also if explicitly stated in the ‘‘Methods’’ section of the
study.
For each study displaying sufficient details to allow replication of
the sample size calculation, calculations were repeated. To be
included in the subgroup of studies that allowed for recalculation,
complete reporting of type I error, one or two tailed test, power,
and assumptions for the intervention and the control groups were
deemed necessary (ie mean and standard deviation of difference
for continuous outcomes and proportions/rate of events and
difference for dichotomous/time to event outcomes). Where only
type I error was not provided, an alpha level of .05 on a two-tailed
test were inferred. The calculations were replicated with statistical
software using the sampsi, stpower, fpower and sampclus family of
commands where necessary (Stata 12.1, Statacorp, College
Station, TX, USA). The standardized difference (%) between
the actual and the estimated sample size was calculated following
the formula:
sample size used{sample size recalculated
sample size used  100
Table 2. Alpha level, power level and type of outcome
for RCTs where recalculation of the sample sizes were
feasible (n =121).
Recalculation Feasible
Alpha (%) No. %
0.01 3 2
0.025 2 2
0.05 109 90
Inferred 0.05 7 6
Power (%)
75 1 1
80 80 66
82 1 1
85 5 4
86 2 2
90 24 20
94 1 1
95 6 5
99 1 1
Outcome
Binary 23 19
Continuous 92 76
Time to event 4 3
Ordinal 2 2
Total 121 100
doi:10.1371/journal.pone.0085949.t002
Table 3. Median, range and interquartile range for
standardized percentage difference where sample
recalculation was feasible (n =121).
N median min max IQR
Journal
AJODO 16 3.5 293.3 45.0 38.5
BJOMS 1 19.3 19.3 19.3 0.0
IJP 6 22.2 253.5 67.6 85.6
JCP 64 19.1 2237.5 61.9 30.7
JE 14 11.3 273.3 84.2 23.7
JADA 5 46.7 266.0 65.5 16.6
JDR 15 15.2 2232.2 72.2 40.0
Continent
Europe 67 12.5 2237.5 84.2 33.3
Americas 35 12.9 273.3 72.2 51.5
Asia/other 19 20.0 2140.0 67.6 29.1
No. authors
1–4 29 4.0 2237.5 84.2 67.4
5–7 66 19.3 2132.3 67.6 27.3
.7 26 13.8 2232.2 72.2 28.8
Trial design
Cluster 4 4.3 211.1 22.6 30.7
Crossover 12 28.2 3.2 84.2 41.3
Factorial 1 26.4 26.4 26.4 0.0
Non-inferiority 5 24.9 2232.2 25.3 37.6
Parallel 86 9.1 2237.5 72.2 38.8
Splitmouth 13 48.4 280.0 65.5 31.3
Methodologist
involvement
No 83 19.4 2237.5 84.2 40.0
Yes 38 4.5 2232.2 46.1 39.6
Center
Single Center 90 12.7 2237.5 84.2 40.1
Multi Center 31 18.2 2232.2 67.6 21.9
Significance
No 53 19.4 2237.5 72.2 32.1
Yes 68 12.5 2232.2 84.2 40.3
No. arms
2 103 14.3 2237.5 84.2 35.0
3 10 10.2 2132.3 58.3 44.6
4 6 30.7 242.9 55.6 88.4
5 1 4.2 4.2 4.2 0.0
8 1 26.4 26.4 26.4 0.0
Total 121 15.2 2237.5 84.2 35.0
doi:10.1371/journal.pone.0085949.t003
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The standardized difference (%) between assumed and observed
square root of variances for continuous outcome estimates was
calculated accordingly:
assumed pooled SD{observed pooled
SDassumed pooled SD  100
The ratio of odd ratios (ROR) of the assumed vs. the observed
ORs or HRs for binary and time-to-event outcome estimates was
also calculated, allowing the degree of under- or over-estimation of
the required sample size to be quantified.
Statistical Analysis
Descriptive statistics were performed for the total number of
RCTs identified in each journal, geographical area, and the
remaining study characteristics. Initially, Pearson chi-squared test
was used to determine the association between sufficient reporting
of sample size calculation, and trial characteristics including
journal of publication, continent of publication, number of
authors, trial design, methodologist involvement, number of
research centers and arms, and significance of the results.
Univariable and multivariable logistic regression modeling was
used to determine the association between the feasibility of sample
size calculation and predictor variables including journal, meth-
odologist involvement, number of research centers and year of
publication).The model fit was assessed using the Hosmer-
Lemeshow test. In the logistic regression analysis, the journal PD
was excluded as no studies with sufficient information to allow
sample size recalculation were reported in this journal. All
statistical analyses were conducted with statistical software (Stata
12.1, Stata Corp, College Station, TX, USA).
Results
Four hundred and thirteen RCTs were identified in eight
leading dental specialty journals (Table 1, Figure 1). The highest
number of RCTs identified was published in JCP followed by JE,
AJODO and JDR. The majority of studies were conducted in a
Table 4. Standardized percentage difference per subgroup for RCTs where recalculation of the sample sizes was
feasible (n =121).
Standardized difference
Subgroup Recalculated.actual* n =35 Recalculated,actual** n=84 Recalculated=actual n=2
median 230.00 23.60 0.00
min 2237.50 1.60 0.00
max 21.70 84.20 0.00
IQR 53.35 22.58 0.00
*Recalculated . actual indicates underestimation of the sample size by the authors of the RCTs and is characterized by negative values for the calculated standardized
difference.
**Recalculated , actual indicates overestimation of the sample size by the authors of the RCTs and is characterized by positive values for the calculated standardized
difference.
doi:10.1371/journal.pone.0085949.t004
Table 5. Univariable and multivariable logistic regression derived ORs and 95% confidence intervals (CI) for the
feasibility of sample size recalculation for the identified Randomized Controlled Trials (n =413).
Predictor variables Univariable analysis Multivariable analysis
Variable Category/Unit OR 95% CI p-value OR 95% CI p-value
Journal AJODO 0.35 0.18, 0.68 0.002 0.39 0.19, 0.80 0.01
BJOMS 0.03 0.00, 0.20 ,0.001 0.04 0.00, 0.29 0.002
IJP 0.23 0.09, 0.59 0.002 0.26 0.10, 0.71 0.01
JCP Baseline (reference)
JE 0.25 0.13, 0.50 ,0.001 0.26 0.13, 0.54 ,0.001
JADA 0.20 0.07, 0.55 0.002 0.15 0.05, 0.43 ,0.001
JDR 0.59 0.29, 1.22 0.16 0.34 0.15, 0.75 0.01
Methodologist involvement No Baseline (reference)
Yes 2.29 1.39, 3.77 0.001 1.97 1.10, 3.53 0.02
Number of centers Single center Baseline (reference)
Multi center 2.03 1.20, 3.45 0.01 1.86 1.01, 3.43 0.046
Year (per year) 1.23 1.12, 1.35 ,0.001 1.24 1.12, 1.38 ,0.001
doi:10.1371/journal.pone.0085949.t005
Sample Size Calculations in Dental Journals
PLOS ONE | www.plosone.org 5 January 2014 | Volume 9 | Issue 1 | e85949
single center, by European researchers without the involvement of
a methodologist. Two-arm parallel trials were most frequent, and
a slight majority of studies reported statistically significant primary
outcomes, whilst most studies involved 5 to 7 authors.
Sufficient data to allow replication of the sample size calculation
was provided in 121 (29.3%) RCTs (Table 2). Most of the studies
pre-specified a power of 80% to correctly identify a difference if
one existed (n = 80, 66%), while in 24 studies (20%) power was set
at 90%. The cut-off point for a false positive result was 5%
(alpha = .05) in almost all of the studies included (n = 116/121).
With regard to the type of the outcome under evaluation,
continuous outcomes predominated (n= 92/121, 76%), followed
by binary outcomes (n = 23/121, 19%), with few studies consid-
ering time-to-event or ordinal outcomes.
The standardized percentage difference between sample size
used and recalculated was determined in the 121 RCTs that
allowed for replication of the calculations (Table 3). The overall
median discrepancy ranged from 2237.5% to 84.2%, with a
Figure 2. Predicted probabilities of adequate sample size reporting with 95% confidence intervals (CIs) derived from the adjusted
model for reporting sample size calculation details based on the journal and year of publication.
doi:10.1371/journal.pone.0085949.g002
Figure 3. Boxplots of percentage standardized difference between assumed and observed variance for continuous outcome from
the RCTs where sample size recalculation was feasible (n=92/121) based on journal of publication. The horizontal line at zero indicates
perfect agreement between assumed and observed variance. Median values below zero indicate optimistic assumptions of variance (smaller than
observed) and vice versa.
doi:10.1371/journal.pone.0085949.g003
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median value of 15.2% (IQR=35); positive values indicate that
the sample size recruited exceeded requirements based on a priori
assumptions. The subgroups of studies that overestimated,
underestimated or correctly calculated the sample size required,
based on a priori assumptions are also presented in Table 4.
Multivariable logistic regression (Table 5) demonstrated that
JCP had the highest odds of adequately reporting sufficient data to
permit sample size recalculation followed by AJODO and JDR,
with 61% (OR=0.39, CI: 0.19, 0.80) and 67% (OR=0.34,
CI:0.15, 0.75) lower odds, respectively. The involvement of a
methodologist in the statistical analysis and trial methodology of
the included studies resulted in 97% higher odds (OR=1.97, CI:
1.10, 3.53) of appropriate reporting. There was evidence that a
multi-center setting also resulted in 86% higher odds of sufficient
reporting to allow recalculation (OR=1.86, CI: 1.01, 3.43). For
each additional year of publication until 2012, the odds of
inclusion of sample size assumptions increased by 24%
(OR=1.24, CI: 1.12, 1.38). The predicted probabilities from the
adjusted model for sufficient sample calculations reporting are
shown by year and journal in Figure 2. The journal PD was
excluded from the logistic regression analysis, as PD did not
contribute any studies with sufficient information to allow sample
recalculation.
Finally, for continuous outcomes, the standardized difference
between assumed and observed variance indicated an overall
median discrepancy of 2.92% (IQR=53.8%; Figure 3); negative
median values (below zero) show overly optimistic assumption on
the expected variance. As for binary and time-to-event outcomes,
the overall median ratio of assumed compared to observed ORs
was 0.61 (IQR=1.01; Figure 4) with values less than 1 indicating
optimistic assumptions on the expected differences in the odds of
events between treatment groups.
The median number of participants required based on the
sample size assumptions in the 121 included RCTs was 42 (range:
10–832), whereas the median number recruited was 50 (range:10–
983) participants. A median of two dropouts per trial was
recorded.
Of the 121 studies that included sufficient data concerning
sample size assumptions, 71 demonstrated some sort of clustering
effect for the primary outcome measure. However, only 10/121
trials accounted for the correlated nature of the data in performing
the sample size calculations at the design stage; clustering was
accounted for in the statistical methods in the majority of these
studies (n = 53, 74.6%).
Discussion
The present work is the first large scale study to analyze the
veracity of sample size calculations of RCTs, along with other
associations in leading specific and general audience dental
journals. The overall median discrepancy identified between
presented and recalculated sample sizes was 15.2% (2237.5%,
84.2%) after making provision for losses to follow-up, indicating a
tendency to slightly over-estimate required numbers. However,
this finding was based on a small portion of RCTs, as inadequate
data to allow for replication of sample size assumptions was typical
(70.7%). This finding mirrors a recent study in orthodontics, which
highlighted that replication of calculations was possible in just
29.5% of the RCTs; the median discrepancy between presented
and recalculated sample size was 5.3%, although recalculations
were conducted on fewer studies (n = 41) [21]. Similarly, in
biomedical research, comprehensive sample size calculations, with
adequate data permitting replication was identified in 34% of
studies [3] and only 19% of studies in the field of plastic surgery
[22].
The multivariable logistic regression model demonstrated that
articles published in JCP had the highest odds for correctly
reporting assumptions for sample size calculation, followed by the
AJODO and the JDR. Evidence of underpowered studies in
periodontology was highlighted in the past; this may have
provoked increased awareness of the necessity for clear and
Figure 4. Boxplots of ratio of Odds Ratios (ORs) of assumed compared to observed ORs or HRs for binary, ordinal and time-to-event
outcomes from the RCTs where sample size recalculation was feasible (n=29/121) based on journal of publication. The horizontal line
at 1 indicates perfect agreement between assumed and observed ORs. Median values below 1 indicate optimistic assumptions of variance (smaller
than observed) and vice versa.
doi:10.1371/journal.pone.0085949.g004
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accurate reporting of sample size calculations within this
specialty[14].
Another finding of note was the discrepancy between the
assumed and observed variances and ORs for the intervention and
control groups. This difference may lead to insufficiently powered
trials lacking the capacity to identify treatment differences risking
incorrect inferences based on inconclusive outcomes [12]. The
discrepancy between the final overestimation of the sample size
compared to assumptions on variance and odds of the events is
related to inflation of the sample size to account for possible losses
to follow-up. The main reasons for inadequate assumptions of
variances are that the assumptions are based on initial piloting,
with the researchers following exactly the same variances for a
much larger RCT, disregarding the fact that variance is not fixed
[11]. Initial piloting within each trial may help optimize sample
calculations. Other methods proposed to overcome the uncertain-
ty of nuisance parameters are ‘‘sample size reviews’’ or ‘‘designs
with internal pilot studies’’ that allow recalculation of the sample
size during the course of a clinical trial, with subsequent
adjustments to the initially planned size [23,24].
The recruitment of a median number of 50 participants in a
dental RCT is often a realistic objective, which may reflect
researchers’ tendency to arrive at an achievable and feasible size of
sample to test the differences between interventions for a research
question. However, whether the appropriate sample size is
determined from valid and pre-specified assumptions for the
intervention groups can rarely be determined. It is possible that
effect sizes and assumptions may be manipulated to arrive at the
desired number of participants [2]. This practice has led to calls
for discontinuation of the usage and reporting of sample size
calculations [25].
This study also confirmed the apparent lack of reporting of
specific trial characteristics, which are necessary for accurate
sample size estimation. In particular, correlated data, which may
contribute to clustering effects and outcomes more closely
matched within clusters than between them, was poorly handled
[26]. The number of studies accounting for these effects was
disappointing with only a small fraction reporting sufficient
information in the sample estimation assumptions.
A limitation of the present work is that outcomes were based
solely on reported information from the included RCTs. Protocols
of RCTs published in trial registries prior to the commencement of
the study would help eliminate possible deviations from a priori
assumptions [27]. However, protocols were rarely identified for
the RCTs included in the present study.
Finally, if reporting of sample size assumptions is to continue,
emphasis should be placed on encouraging researchers, authors,
editors and peer reviewers to overhaul the reporting quality of
submitted clinical trials prior to publication, in line with the
CONSORT guidelines for clear and transparent reporting.
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